Cargando…

Real‐world results with IgPro20 for hypo‐ or agammaglobulinemia in Japan

BACKGROUND: Subcutaneous immunoglobulin is one of the standard treatments for hypogammaglobulinemia in primary immunodeficiencies (PID) worldwide. In Japan, IgPro20 (Hizentra(®); l‐proline‐stabilized 20% human subcutaneous immunoglobulin) is approved for agammaglobulinemia or hypogammaglobulinemia d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imai, Kohsuke, Ishii, Tomonori, Nonoyama, Shigeaki, Yasumi, Takahiro, Kanegane, Hirokazu, Fukushima, Taku, Matsumaru, Masayuki, Akasaki, Tetsushi, Usui, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099597/ https://www.ncbi.nlm.nih.gov/pubmed/36151913 http://dx.doi.org/10.1111/ped.15362

Ejemplares similares

Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases
por: Kanegane, Hirokazu, et al.
Publicado: (2014)

Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity
por: Ikegame, Kazuhiro, et al.
Publicado: (2016)

A Dual Reporter Splicing Assay Using HaloTag-containing Proteins
por: Oshima, Koichi, et al.
Publicado: (2012)

Fatal Progressive Meningoencephalitis Diagnosed in Two Members of a Family With X-Linked Agammaglobulinemia
por: Kasahara, Yasushi, et al.
Publicado: (2020)

Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency
por: Rojavin, Mikhail A., et al.
Publicado: (2019)

Oral management of a patient with down syndrome and agammaglobulinemia: a case report
por: Kusumoto, Yasuka, et al.
Publicado: (2020)

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial
por: Merkies, Ingemar S. J., et al.
Publicado: (2017)

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study
por: van Schaik, Ivo N., et al.
Publicado: (2019)

Mutations of the Igβ gene cause agammaglobulinemia in man
por: Ferrari, Simona, et al.
Publicado: (2007)

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency
por: Hagan, John B., et al.
Publicado: (2010)

The Primary Immunodeficiency Database in Japan
por: Mitsui-Sekinaka, Kanako, et al.
Publicado: (2022)

Clinical and Genetic Profile of X-Linked Agammaglobulinemia: A Multicenter Experience From India
por: Rawat, Amit, et al.
Publicado: (2021)

Switch from intravenous to subcutaneous immunoglobulin IgPro20 in CIDP patients: a prospective observational study under real-world conditions
por: Gingele, Stefan, et al.
Publicado: (2021)

A complementary approach for genetic diagnosis of inborn errors of immunity using proteogenomic analysis
por: Sakura, Fumiaki, et al.
Publicado: (2023)

A Budget Impact Model of Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with IgPro20 (Hizentra) Relative to Intravenous Immunoglobulin in the United States
por: Mallick, Rajiv, et al.
Publicado: (2023)

Functional analysis of novel A20 variants in patients with atypical inflammatory diseases
por: Kadowaki, Saori, et al.
Publicado: (2021)

Bruton's Agammaglobulinemia and COVID-19
por: Hovey, Justin G, et al.
Publicado: (2020)

Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study
por: Anderson, John T., et al.
Publicado: (2021)

Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as X-linked agammaglobulinemia in adults
por: Usui, Kazuhiro, et al.
Publicado: (2001)

Correction: Bruton's Agammaglobulinemia and COVID-19
por: Hovey, Justin G, et al.
Publicado: (2021)

Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports
por: Shebl, Amgad, et al.
Publicado: (2020)

Plasma therapy leads to an increase in functional IgA and IgM concentration in the blood and saliva of a patient with X-linked agammaglobulinemia
por: Langereis, Jeroen D., et al.
Publicado: (2019)

Clinical Courses of IKAROS and CTLA4 Deficiencies: A Systematic Literature Review and Retrospective Longitudinal Study
por: Hoshino, Akihiro, et al.
Publicado: (2022)

Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study
por: Cowan, Juthaporn, et al.
Publicado: (2020)

X-linked agammaglobulinemia (XLA): Phenotype, diagnosis, and therapeutic challenges around the world
por: El-Sayed, Zeinab A., et al.
Publicado: (2019)

Case Report: A Case of X-Linked Agammaglobulinemia With High Serum IgE Levels and Allergic Rhinitis
por: Cinicola, Bianca, et al.
Publicado: (2020)

A Case of Fabry's Disease with Congenital Agammaglobulinemia
por: Lee, Ki-Yeol, et al.
Publicado: (2011)

Astrovirus Encephalitis in Boy with X-linked Agammaglobulinemia
por: Quan, Phenix-Lan, et al.
Publicado: (2010)

X-linked Agammaglobulinemia Presenting with Multiviral Pneumonia
por: Arroyo-Martinez, Yadis M, et al.
Publicado: (2020)

Autism in a Child With X-linked Agammaglobulinemia
por: Bied, Adam, et al.
Publicado: (2022)

Vegetative Skin Lesions in Patient with Bruton's Agammaglobulinemia
por: Fidanzi, Cristian, et al.
Publicado: (2023)

Hypo and Hyperthyroidism
por: Hixson, J. S.
Publicado: (1915)

Specificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region
por: Hiki, Yoshiyuki, et al.
Publicado: (2014)

Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes
por: Fujimoto, Masaya, et al.
Publicado: (2008)

INFECTIOUS AGAMMAGLOBULINEMIA: TRANSMISSION OF IMMUNODEFICIENCY WITH GRAFTS OF AGAMMAGLOBULINEMIC CELLS
por: Blaese, R. Michael, et al.
Publicado: (1974)

Membranoproliferative Glomerulonephritis and X-Linked Agammaglobulinemia: An Uncommon Association
por: Lavrador, Vasco, et al.
Publicado: (2014)

Splice-Correction Strategies for Treatment of X-Linked Agammaglobulinemia
por: Bestas, Burcu, et al.
Publicado: (2015)

Disseminated Spiroplasma apis Infection in Patient with Agammaglobulinemia, France
por: Etienne, Nicolas, et al.
Publicado: (2018)

Pyoderma Gangrenosum in a Patient with X-Linked Agammaglobulinemia
por: Tan, Qi, et al.
Publicado: (2017)

Agammaglobulinemia: from X-linked to Autosomal Forms of Disease
por: Cardenas-Morales, Melissa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2eonq3k1da4ok11h3kermu8t03